Type 1 diabetes monitoring and ophthalmic complications in children in the Democratic Républic of Congo

Trial ID: ISRCTN13277803

Interventional - Phase Unknown - No longer recruiting

The use of continuous glucose monitoring (CGM) sensors can improve diabetes management and the progression of microangiopathic complications (diabetic retinopathy) in children with type 1 diabetes in the city of Kinshasa in the Democratic Republic of the Congo

Conditions

• Type 1 diabetes, diabetic retinopathy

Interventions

• Dexcom ONE sensor

Eligibility

Inclusion criteria

• 1. Children under 18 years of age, of both sexes, followed in the six diabetic clinics in Kinshasa
• 2. Known diabetic with diabetic retinopathy
• 3. No-sickle cell children
• 4. Informed consent from parents

Exclusion criteria

• 1. Age over 18 years
• 2. Non-type1 diabetes millitus
• 3. Non-consent

Sponsor

University Clinic of Kinshasa

Last updated: 2025-03-07 · Source: https://www.isrctn.com/

Search more clinical trials on myTomorrows